Target intelligence / Profile preview

Epidermal growth factor receptor tyrosine kinase catalytic domain (EGFR TK domain)

Target
EGFR TK domain
Molecular classification
Enzyme, Receptor tyrosine kinase, Catalytic domain of receptor protein
01

Overview

The epidermal growth factor receptor tyrosine kinase catalytic domain is a cytoplasmic region within the larger transmembrane receptor known as EGFR. This catalytic portion is responsible for transferring a phosphate group from ATP to specific tyrosine residues on target proteins—a process called phosphorylation. Ligand binding at the extracellular region induces dimerization of two receptors, which activates their intracellular kinases through autophosphorylation. The resulting signal cascade regulates key cellular processes such as proliferation, differentiation, and survival. Dysregulation or mutation in this region is strongly implicated in various cancers due to uncontrolled cell division.

Other names
EGFR kinase domainErbB1 tyrosine kinase domainHER1 tyrosine kinase domain
02

Mechanism of action

Drugs targeting this molecule typically act as ATP competitors or allosteric inhibitors, blocking the transfer of a phosphate group from ATP to substrate proteins. This inhibits downstream signaling pathways responsible for cell proliferation and survival.

03

Biological functions

Signal transductionCell proliferationCell differentiationCell survival and division
04

Disease associations

Cancer (notably non-small cell lung cancer, colorectal cancer, head and neck cancers)Other proliferative disorders
05

Safety considerations

skin toxicity (rash)diarrheainterstitial lung diseasehepatotoxicityacquired resistance due to secondary mutations
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

Phosphorylation status of EGFR (e.g., phospho-EGFR)presence of activating mutations in the EGFR gene (such as L858R or exon 19 deletions)amplification/overexpression of EGFR protein

Beyond the preview

Go deeper on Epidermal growth factor receptor tyrosine kinase catalytic domain (EGFR TK domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal growth factor receptor tyrosine kinase catalytic domain (EGFR TK domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call